| Figen Yildiz, CRNP | |
|
1235 Old York Rd Ste 210, Abington, PA 19001-3841 | |
| (215) 659-3220 | |
| (215) 659-8967 |
| Full Name | Figen Yildiz |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1235 Old York Rd Ste 210, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821553470 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
News Archive
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
Cappella Medical Devices presented new clinical data on its unique Sideguard® coronary sidebranch system today at the International JIM 2011 in Rome, Italy.
Variations in a gene known as SORL1 may be a factor in the development of late onset Alzheimer's disease, an international team of researchers has discovered. The genetic clue, which could lead to a better understanding of one cause of Alzheimer's, is reported in Nature Genetics online, and was supported in part by the National Institutes of Health (NIH).
Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.
› Verified 1 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154376739 PECOS PAC ID: 3274437736 Enrollment ID: O20040114000208 |
News Archive
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
Cappella Medical Devices presented new clinical data on its unique Sideguard® coronary sidebranch system today at the International JIM 2011 in Rome, Italy.
Variations in a gene known as SORL1 may be a factor in the development of late onset Alzheimer's disease, an international team of researchers has discovered. The genetic clue, which could lead to a better understanding of one cause of Alzheimer's, is reported in Nature Genetics online, and was supported in part by the National Institutes of Health (NIH).
Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.
› Verified 1 days ago
| Entity Name | Abington Emergency Physician Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659359099 PECOS PAC ID: 1052305380 Enrollment ID: O20040412000218 |
News Archive
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
Cappella Medical Devices presented new clinical data on its unique Sideguard® coronary sidebranch system today at the International JIM 2011 in Rome, Italy.
Variations in a gene known as SORL1 may be a factor in the development of late onset Alzheimer's disease, an international team of researchers has discovered. The genetic clue, which could lead to a better understanding of one cause of Alzheimer's, is reported in Nature Genetics online, and was supported in part by the National Institutes of Health (NIH).
Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Figen Yildiz, CRNP 2500 Maryland Rd Ste 400, Willow Grove, PA 19090-1225 Ph: (215) 481-4143 | Figen Yildiz, CRNP 1235 Old York Rd Ste 210, Abington, PA 19001-3841 Ph: (215) 659-3220 |
News Archive
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
Cappella Medical Devices presented new clinical data on its unique Sideguard® coronary sidebranch system today at the International JIM 2011 in Rome, Italy.
Variations in a gene known as SORL1 may be a factor in the development of late onset Alzheimer's disease, an international team of researchers has discovered. The genetic clue, which could lead to a better understanding of one cause of Alzheimer's, is reported in Nature Genetics online, and was supported in part by the National Institutes of Health (NIH).
Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.
› Verified 1 days ago